More than 7M Americans have received updated COVID shots
JUN LI/iStock via Getty Images

Over 7M people in the U.S. have obtained the COVID-19 shots redesigned for the recently-emerged XBB.1.5 Omicron subvariant as of Wednesday, the U.S. Department of Health and Human Services said as the country marks the first month of the new vaccine rollout.
The Centers for Disease Control and Prevention (CDC) recommended the updated messenger-RNA-based COVID shots developed by Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) in September for people aged six months and older.
Novavax (NASDAQ:NVAX) received regulatory clearance for its protein-based shot early this month for individuals aged 12 years and older, including those who previously received mRNA-based shots.

This yearâs immunization drive marks the first time COVID-19 vaccines are offered through commercial markets. According to CDC data, about 56.5M Americans received bivalent COVID-19 shots introduced last year.
The September figure for administered COVID shots stood at 4M about two weeks after the rollout.



More on BioNTech, Moderna, etc.

Novavax's COVID-19 Investment Thesis Is Old News
Investing In Moderna: A Speculative Buy For Long-Term Gains
BioNTech: This Beaten Pandemic Star Will Capitalize On Oncology Treatments
Pfizer wins FDA nod to expand label for Braftovi + Mektovi in lung cancer
Regulators looking at impact on innovation in review of Seagen/Pfizer - report